Cargando…
Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa
BACKGROUND: The importation of malaria to non-endemic countries remains a major cause of travel-related morbidity and a leading cause of travel-related hospitalizations. Currently they are three priority medications for malaria prophylaxis to West Africa: mefloquine, atovaquone/proguanil and doxycyc...
Autores principales: | Widmer, Lukas L, Blank, Patricia R, Van Herck, Koen, Hatz, Christoph, Schlagenhauf, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161358/ https://www.ncbi.nlm.nih.gov/pubmed/20860809 http://dx.doi.org/10.1186/1471-2334-10-279 |
Ejemplares similares
-
The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
por: Behrens, Ron H, et al.
Publicado: (2007) -
The position of mefloquine as a 21(st )century malaria chemoprophylaxis
por: Schlagenhauf, Patricia, et al.
Publicado: (2010) -
Towards improved uptake of malaria chemoprophylaxis among West African travellers: identification of behavioural determinants
por: Wieten, Rosanne W, et al.
Publicado: (2013) -
Cost risk benefit analysis to support chemoprophylaxis policy for travellers to
malaria endemic countries
por: Massad, Eduardo, et al.
Publicado: (2011) -
Failure of malaria chemoprophylaxis with mefloquine in an oversize traveller to Mozambique
por: Gobbi, Federico, et al.
Publicado: (2013)